Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a Head-Zap device ease Parkinson's at home?

NCT ID NCT07548801

First seen Apr 30, 2026 · Last updated Jun 19, 2026 · Updated 8 times

Summary

This study tests whether a gentle electrical current applied to the back of the head (cerebellar tDCS) can improve both movement and mood in people with mild to moderate Parkinson's disease. Twenty-five participants will use a portable device at home for 8 days. Researchers will measure changes in motor skills, thinking, anxiety, and quality of life before and after treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hopital Erasme

    Brussels, 1070, Belgium

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

cerebellar transcranial direct current stimulation (ctDCS) device

What this could lead to

If it works, this could offer a safe, portable, at-home option to help manage both movement and mood symptoms in Parkinson's disease.

What could go wrong

This is a very small, early study with only 25 people and no control group. Results may not apply to everyone, and the effect may be modest or temporary.

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.